Panax quinquefolius whole

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Panax quinquefolius whole
Accession Number
DB14296
Type
Biotech
Groups
Experimental, Investigational
Description

Panax quinquefolius whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Synonyms
  • American Ginseng
  • American Ginseng Whole
  • Panax Quinquefolium Whole
  • Panax Quinquefolius
  • Sang Whole
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Mirapharm 22Capsule0.06 g/1OralMirapharm., Inc.2015-02-06Not applicableUs
SUPER MIRAPHARM (0.3g)Capsule0.0006 g/1OralMirapharm., Inc.2015-01-31Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Mirapharm 22Panax quinquefolius whole (0.06 g/1)CapsuleOralMirapharm., Inc.2015-02-06Not applicableUs
SUPER MIRAPHARM (0.3g)Panax quinquefolius whole (0.0006 g/1)CapsuleOralMirapharm., Inc.2015-01-31Not applicableUs
Categories
Not Available
UNII
8W75VCV53Q
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentHIV/AIDS-associated Fatigue1
3CompletedSupportive CareChronic Myeloproliferative Disorders / Leukemias / Lymphoproliferative Disorders / Malignant Lymphomas / Multiple Myeloma and Plasma Cell Neoplasm / Myelodysplastic Syndromes / Myelodysplastic/Myeloproliferative Neoplasms / Precancerous Conditions / Tiredness / Unspecified Adult Solid Tumor, Protocol Specific1
3CompletedTreatmentHigh Blood Pressure (Hypertension)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
CapsuleOral0.06 g/1
CapsuleOral0.0006 g/1
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on July 05, 2018 11:13 / Updated on May 01, 2019 11:59